Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an announcement.
WuXi AppTec Co., Ltd. has announced significant changes to its corporate structure and capital. The company plans to cancel its Supervisory Committee to enhance corporate governance, with the Audit Committee taking over its functions. Additionally, following recent share repurchases and placements, the company proposes to increase its registered capital, necessitating amendments to its Articles of Association. These changes are aimed at aligning with regulatory requirements and optimizing the company’s operational framework.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company focuses on providing comprehensive and integrated services in the areas of drug discovery, development, and manufacturing.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
Find detailed analytics on 2359 stock on TipRanks’ Stock Analysis page.